USANA Health Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 27, 2025	Dec '24 Dec 28, 2024	Dec '23 Dec 30, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Jan '21 Jan 2, 2021
Cash & Equivalents	145.35	181.77	330.42	288.42	239.83	311.92
Cash & Short-Term Investments	145.35	181.77	330.42	288.42	239.83	311.92
Cash Growth	-60.17%	-44.99%	14.56%	20.26%	-23.11%	32.83%
Other Receivables	-	8.22	7.2	7.21	7.16	7.42
Receivables	-	8.22	7.2	7.21	7.16	7.42
Inventory	91.28	69.74	61.45	67.09	98.32	90.22
Prepaid Expenses	27.44	13.76	11.39	11.38	13.85	8.68
Restricted Cash	-	-	-	-	-	0.96
Other Current Assets	-	5.7	7.28	10.28	5.95	6.08
Total Current Assets	264.07	279.19	417.75	384.38	365.12	425.29
Property, Plant & Equipment	96.21	111.12	107.68	111.69	120.07	117.33
Long-Term Investments	20	20	-	-	-	20
Goodwill	144.29	144.17	17.1	17.37	17.67	17.37
Other Intangible Assets	138.16	151.82	29.92	32.43	30.44	30.8
Long-Term Deferred Tax Assets	24.16	19.64	13.28	9.8	4.84	4.64
Other Long-Term Assets	39.71	22.25	47.03	40.88	39.6	25.47
Total Assets	726.59	748.19	632.76	596.55	577.74	640.89
Accounts Payable	16.22	11.98	10.07	11.05	13.51	18.2
Accrued Expenses	-	79.57	80.84	84.26	97.63	99.13
Short-Term Debt	-	23	0.79	-	-	-
Current Portion of Leases	-	6.01	7.28	6.89	7.08	8.62
Current Income Taxes Payable	-	3.71	3.3	4.97	5.19	7.76
Current Unearned Revenue	11.04	12.05	13.91	20.88	19.64	15.95
Other Current Liabilities	91.41	3.3	2.66	15.79	17.75	18.42
Total Current Liabilities	118.66	139.63	118.85	143.83	160.79	168.07
Long-Term Leases	-	10.19	5.14	7.68	10.22	12.86
Long-Term Deferred Tax Liabilities	4.47	4.07	4.55	4.07	7.5	12.01
Other Long-Term Liabilities	21.91	7.97	7.02	6.49	4.11	6.3
Total Liabilities	145.04	161.86	135.56	162.08	182.62	199.24
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	79.85	75.82	65.66	55.6	50.01	62.46
Retained Earnings	467.5	478.94	445.22	391.64	344.64	382.79
Comprehensive Income & Other	-19.29	-22.67	-13.7	-12.79	0.46	-3.63
Total Common Equity	528.07	532.11	497.2	434.47	395.12	441.65
Minority Interest	53.48	54.22	-	-	-	-
Shareholders' Equity	581.55	586.33	497.2	434.47	395.12	441.65
Total Liabilities & Equity	726.59	748.19	632.76	596.55	577.74	640.89
Total Debt	-	39.2	13.21	14.57	17.3	21.47
Net Cash (Debt)	145.35	142.56	317.22	273.85	222.54	290.45
Net Cash Growth	-60.17%	-55.06%	15.84%	23.06%	-23.38%	38.81%
Net Cash Per Share	7.74	7.44	16.40	14.18	10.94	13.66
Filing Date Shares Outstanding	18.28	18.9	19.24	19.29	19.32	20.85
Total Common Shares Outstanding	18.27	19.06	19.13	19.21	19.39	21.04
Working Capital	145.4	139.56	298.9	240.55	204.33	257.21
Book Value Per Share	28.90	27.91	25.99	22.62	20.37	20.99
Tangible Book Value	245.63	236.12	450.18	384.67	347.01	393.49
Tangible Book Value Per Share	13.44	12.39	23.53	20.03	17.89	18.70
Land	-	6.36	6.72	6.72	6.99	7.25
Buildings	-	76.68	77.8	78.07	80.82	79.67
Machinery	-	121.16	116.82	113.99	111.47	100.39
Leasehold Improvements	-	12.61	14.34	14.39	15.21	15.24

Updated Oct 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q